Innomar Strategies Enhances Commercialization Expertise with Acquisition of Therapeutic Products Inc.
May 3, 2018
Since 2013, TPIreg has been a leader in the Canadian
healthcare landscape, with expertise in providing regulatory and quality
assurance consultation to specialty pharmaceutical manufacturers in North
America, as well as international companies focused on entry into the Canadian
market. Anne Tomalin, Founder of TPIreg, will join Innomar. She is one of Canada’s leading experts in
regulatory affairs and brings more than 25 years of industry experience to the
company along with significant relationships with Canadian regulators.
“At Innomar Strategies, we are committed to advancing the commercialization of specialty pharmaceuticals and delivering value to our patients and partners across the Canadian healthcare system,” said Guy Payette, President, Innomar Strategies. “TPIreg is dedicated to this same mission and we believe that together, our best-in-class combination of resources, solutions and expertise allows us to offer customers a true integration of commercialization services, including supporting full market authorization into Canada.”
Accompanying Tomalin is her team of renowned experts who will support Innomar in the key areas of Regulatory Marketing and clinical trial applications, Quality Assurance, Drug Establishment Licensing (DEL) and support, and post marketing regulatory activities regarding safety and supply chain management.
“TPIreg will benefit from Innomar’s broad expertise and looks forward to contributing to a suite of commercialization services for companies wanting to enter the pharmaceutical market in Canada,” said Anne Tomalin, President, TPIreg. “We are excited to join Innomar and accelerate our pace of innovation.”
Innomar Strategies offers a broad suite of customized, end-to-end commercialization solutions, including market access consulting, patient support programs, nursing and clinic services, and specialty pharmacy and logistics management.